Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Rf, Spiera"'
Publikováno v:
Europe PubMed Central
To review the literature examining the association of silicone gel filled implants and connective tissue disease.Computerized literature searches and manual review of bibliographies.Numerous concerns have arisen regarding the safety of silicone gel f
Autor:
Lakin KS; Hospital for Special Surgery, New York, New York, USA. Electronic address: LakinK@hss.edu., Wu Y; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada., Gordon JK; Hospital for Special Surgery, New York, New York, USA., Kwakkenbos L; Department of Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands; Department of IQ Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Psychiatry, Centre for Mindfulness, Radboud University Medical Center, Nijmegen, the Netherlands., Carrier ME; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada., Henry RS; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada., Denton CP; University College London, Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, London, UK., Mouthon L; Service de Médecine Interne, Centre de Référence Maladies Autoimmunes et Autoinflammatoires Systémiques Rares d'Ile de France, de l'Est et de l'Ouest, Hôpital Cochin, Paris, France; Assistance Publique Hôpitaux de Paris-Centre, Hôpital Cochin, Université Paris Cité, Paris, France., Spiera RF; Hospital for Special Surgery, New York, New York, USA., Thombs BD; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada; Department of Medicine, McGill University, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada; Biomedical Ethics Unit, McGill University, Montreal, Quebec, Canada; Department of Psychology, McGill University, Montreal, Quebec, Canada.
Publikováno v:
Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2024 Aug; Vol. 67, pp. 152453. Date of Electronic Publication: 2024 May 09.
Autor:
Spiera RF; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Unizony S; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Warrington KJ; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Sloane J; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Giannelou A; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Nivens MC; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Akinlade B; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Wong W; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Bhore R; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Lin Y; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Buttgereit F; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Devauchelle-Pensec V; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Rubbert-Roth A; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Yancopoulos GD; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Marrache F; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Patel N; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.)., Dasgupta B; From the Hospital for Special Surgery, Weill Cornell Medical College, New York (R.F.S.), and Regeneron Pharmaceuticals, Tarrytown (A.G., M.C.N., B.A., R.B., G.D.Y.) - both in New York; the Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital, Harvard Medical School, Boston (S.U.), and Sanofi, Cambridge (J.S., N.P.) - both in Massachusetts; the Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN (K.J.W.); Sanofi, Bridgewater, NJ (W.W., Y.L.); the Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin (F.B.); CHRU de Brest, Service de Rhumatologie, Brest (V.D.-P.), and Sanofi, Chilly-Mazarin (F.M.) - both in France; the Division of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland (A.R.-R.); and Anglia Ruskin University, Cambridge, United Kingdom (B.D.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2023 Oct 05; Vol. 389 (14), pp. 1263-1272.
Autor:
Casal Moura M; Mayo Clinic and Foundation, Rochester, Minnesota, and Faculdade de Medicina da Universidade do Porto, Porto, Portugal., Thompson GE; Mayo Clinic and Foundation, Rochester, Minnesota., Nelson DR; Mayo Clinic and Foundation, Rochester, Minnesota., Fussner LA; Mayo Clinic and Foundation, Rochester, Minnesota, and the Ohio State University, Columbus, Ohio., Hummel AM; Mayo Clinic and Foundation, Rochester, Minnesota., Jenne DE; Max-Planck-Institute for Biological Intelligence, Martinsried, Germany., Emerling D; Atreca, Inc., Redwood City, California., Fervenza FC; Mayo Clinic and Foundation, Rochester, Minnesota., Kallenberg CGM; University of Groningen, Groningen, The Netherlands., Langford CA; Cleveland Clinic Foundation, Cleveland, Ohio., McCune WJ; University of Michigan, Ann Arbor., Merkel PA; University of Pennsylvania, Philadelphia., Monach PA; VA Boston Healthcare System, Rheumatology, Boston, Massachusetts., Seo P; Johns Hopkins University, Baltimore, Maryland., Spiera RF; Hospital for Special Surgery, New York., St Clair EW; Duke University, Durham, North Carolina., Ytterberg SR; Mayo Clinic and Foundation, Rochester, Minnesota., Stone JH; Massachusetts General Hospital, Boston., Robinson WH; Stanford University and VA Palo Alto, Palo Alto, California., Specks U; Mayo Clinic and Foundation, Rochester, Minnesota.
Publikováno v:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 May; Vol. 75 (5), pp. 748-759. Date of Electronic Publication: 2023 Mar 07.
Autor:
Berti A; Division of Pulmonary & Critical Care Medicine, Thoracic Disease Research Unit, Mayo Clinic, Rochester, Minnesota, and Center for Medical Sciences (CISMed), Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Italy, and Rheumatology Unit, Santa Chiara Hospital, APSS Trento, Italy., Hillion S; Université de Bretagne Occidendale, Brest, Bretagne, France., Konig MF; Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland., Moura MC; Division of Pulmonary & Critical Care Medicine, Thoracic Disease Research Unit, Mayo Clinic, Rochester, Minnesota., Hummel AM; Division of Pulmonary & Critical Care Medicine, Thoracic Disease Research Unit, Mayo Clinic, Rochester, Minnesota., Carmona E; Division of Pulmonary & Critical Care Medicine, Thoracic Disease Research Unit, Mayo Clinic, Rochester, Minnesota., Peikert T; Division of Pulmonary & Critical Care Medicine, Thoracic Disease Research Unit, Mayo Clinic, Rochester, Minnesota., Fervenza FC; Division of Nephrology & Hypertension, Mayo Clinic, Rochester, Minnesota., Kallenberg CGM; Department of Rheumatology and Clinical Immunology, University of Groningen, Groningen, The Netherlands., Langford CA; Cleveland Clinic, Cleveland, Ohio., Merkel PA; Division of Rheumatology, Department of Medicine, and Department of Biostatistics, Epidemiology, and Informatics, Division of Clinical Epidemiology, University of Pennsylvania, Philadelphia., Monach PA; Brigham and Women's Hospital, Boston, Massachusetts., Seo P; Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland., Spiera RF; Weill Cornell Medical College, Hospital for Special Surgery, New York., Brunetta P; Genentech, Inc, San Francisco, California., St Clair EW; Duke University, Durham, North Carolina., Harris KM; Immune Tolerance Network, Bethesda, Maryland., Stone JH; Massachusetts General Hospital Rheumatology Unit, Boston., Grandi G; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Italy., Pers JO; Université de Bretagne Occidendale, Brest, Bretagne, France., Specks U; Division of Pulmonary & Critical Care Medicine, Thoracic Disease Research Unit, Mayo Clinic, Rochester, Minnesota., Cornec D; Université de Bretagne Occidendale, Brest, Bretagne, France.
Publikováno v:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2023 May; Vol. 75 (5), pp. 736-747. Date of Electronic Publication: 2023 Mar 15.
Autor:
Casal Moura M; Pulmonary and Critical Care Medicine, Mayo Foundation for Medical Education and Research, Rochester, Minnesota, USA.; Biomedicina, Faculty of Medicine, University of Porto, Porto, Portugal., Deng Z; National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Brooks SR; Office of Science and Technology, Biodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Tew W; ITGR Diagnostics Discovery, Genentech Inc, South San Francisco, California, USA., Fervenza FC; Nephrology and Hypertension, Mayo Foundation for Medical Education and Research, Rochester, Minnesota, USA., Kallenberg CGM; Rheumatology and Clinical Immunology, University of Groningen, Groningen, The Netherlands., Langford CA; Rheumatic and Immunologic Disease, Cleveland Clinic, Cleveland, Ohio, USA., Merkel PA; Division of Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Monach PA; Department of Medicine, VA Boston Healthcare System, West Roxbury, Massachusetts, USA., Seo P; Rheumatology, Johns Hopkins, Baltimore, Maryland, USA., Spiera RF; Department of Medicine, Hospital for Special Surgery, New York, New York, USA., St Clair EW; Medicine, Duke University, Durham, North Carolina, USA., Stone JH; Vasculitis and Glomerulonephritis Center, Rheumatology, Immunology and Allergy Division, Massachusetts General Hospital, Boston, Massachusetts, USA., Prunotto M; School of Pharmaceutical Sciences, University of Geneva, Geneve, Switzerland., Grayson PC; Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Specks U; Pulmonary and Critical Care Medicine, Mayo Foundation for Medical Education and Research, Rochester, Minnesota, USA specks.ulrich@mayo.edu.
Publikováno v:
RMD open [RMD Open] 2023 Mar; Vol. 9 (1).
Autor:
Chaudhary V; HSS Research Institute and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY.; Department of Microbiology and Immunology, Weill Cornell Medical College of Cornell University, New York, NY., Ah Kioon MD; HSS Research Institute and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY., Hwang SM; Sandra and Edward Meyer Cancer Center and Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY., Mishra B; HSS Research Institute and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY.; Immunology and Microbial Pathogenesis Program, Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY., Lakin K; Department of Medicine, Division of Rheumatology and Scleroderma and Vasculitis Center, Hospital for Special Surgery, New York, NY., Kirou KA; Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, New York, NY., Zhang-Sun J; Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, New York, NY., Wiseman RL; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA., Spiera RF; Department of Medicine, Division of Rheumatology and Scleroderma and Vasculitis Center, Hospital for Special Surgery, New York, NY., Crow MK; HSS Research Institute and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY.; Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, New York, NY.; Department of Medicine, Weill Cornell Medicine, New York, NY., Gordon JK; Department of Medicine, Division of Rheumatology and Scleroderma and Vasculitis Center, Hospital for Special Surgery, New York, NY., Cubillos-Ruiz JR; Sandra and Edward Meyer Cancer Center and Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY.; Immunology and Microbial Pathogenesis Program, Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY., Barrat FJ; HSS Research Institute and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY.; Immunology and Microbial Pathogenesis Program, Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY.; Department of Microbiology and Immunology, Weill Cornell Medical College of Cornell University, New York, NY.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2022 Nov 07; Vol. 219 (11). Date of Electronic Publication: 2022 Sep 02.
Autor:
Sattui SE; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY.; Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA., Jannat-Khah D; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Lally L; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Lieber SB; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Mandl LA; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Spiera RF; Division of Rheumatology, Department of Medicine, Hospital for Special Surgery, New York, NY.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Publikováno v:
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2022 Nov 02; Vol. 61 (11), pp. 4455-4464.
Autor:
Becetti K; Hamad Medical Corporation, Doha, Qatar., Nguyen JT; Hospital for Special Surgery, New York City, New York., Kwakkenbos L; Behavioural Science Institute, Radboud University, Nijmegen, the Netherlands., Carrier ME; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada., Tao L; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada., Gordon JK; Hospital for Special Surgery, New York City, New York., Mancuso CA; Hospital for Special Surgery, New York City, New York., Welling J; Dutch Patient Organization for Systemic Autoimmune Diseases, Utrecht, the Netherlands, and Federation of European Scleroderma Associations, Brussels, Belgium., Mouthon L; Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, and Hôpital Cochin, Paris, France., Bartlett SJ; McGill University and McGill University Health Center Research Institute, Montreal, Quebec, Canada., Malcarne VL; San Diego State University, San Diego, California., Thombs BD; Lady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Montreal, Quebec, Canada., Spiera RF; Hospital for Special Surgery, New York City, New York.
Publikováno v:
ACR open rheumatology [ACR Open Rheumatol] 2022 Aug; Vol. 4 (8), pp. 647-657. Date of Electronic Publication: 2022 May 23.
Autor:
Lally L; L. Lally, MD, R.F. Spiera, MD, Department of Rheumatology, Hospitalfor Special Surgery, Department of Medicine, Weill Cornell Medicine, New York, New York, USA; lallyl@hss.edu., Narula N; N. Narula, MD, Department of Pathology, NYU Langone, New York, New York, USA., Goodfellow N; N. Goodfellow, MD, R. Luqmani, DM, FRCP, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Luqmani R; N. Goodfellow, MD, R. Luqmani, DM, FRCP, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Pisapia D; D. Pisapia, MD, Department of Pathology, Weill Cornell Medicine, New York, New York, USA., Spiera RF; L. Lally, MD, R.F. Spiera, MD, Department of Rheumatology, Hospitalfor Special Surgery, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
Publikováno v:
The Journal of rheumatology [J Rheumatol] 2022 Aug; Vol. 49 (8), pp. 908-912. Date of Electronic Publication: 2022 Apr 15.